Defence Therapeutics Inc. | WebDisclosure

Basculer en Français

10401	Companies
217363	Keywords
146996	Articles
115066	Press releases

Headlines Articles Press releases Defence Therapeutics Inc.

Home
Companies
Defence Therapeutics Inc.

PRESS RELEASE

published on 06/17/2024 at 08:00, 1 year 10 months ago

DEFENCE’S CHIEF SCIENTIFIC OFFICER DR. MOUTIH RAFEI DISCUSSES THE ACCUM PLATFORM FOR CANCER TREATMENTS ON MONEY TALK RADIO WITH ELLIS MARTIN
Defence Therapeutics Inc.'s Chief Scientific Officer Dr. Moutih Rafei discusses the ACCUM platform for cancer treatments on Money Talk Radio with Ellis Martin

Defence Therapeutics Inc. Cancer Treatments ACCUM Platform Dr. Moutih Rafei Money Talk Radio
BRIEF

published on 06/10/2024 at 08:05, 1 year 11 months ago

Defence Therapeutics participera au congrès annuel 2024 du SNMMI à Toronto

Thérapeutique De Défense SNMMI AccuTRIC™ Médecine Nucléaire Imagerie Moléculaire
BRIEF

published on 06/10/2024 at 08:05, 1 year 11 months ago

Defence Therapeutics to Attend 2024 SNMMI Annual Meeting in Toronto

Defence Therapeutics Nuclear Medicine SNMMI AccuTRIC™ Molecular Imaging
PRESS RELEASE

published on 06/10/2024 at 08:00, 1 year 11 months ago

DEFENCE TO PARTICIPATE TO 2024 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING IN TORONTO ON JUNE 11, 2024
Defence Therapeutics Inc. to participate in the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024, presenting their novel Radio-Immuno-Conjugate (RIC) for cancer treatment

Cancer Treatment Defence Therapeutics Inc. Molecular Imaging Society Of Nuclear Medicine Radio-Immuno-Conjugate
BRIEF

published on 06/06/2024 at 08:05, 1 year 11 months ago

L'étude AccuTOX de Defense Therapeutics publiée dans le Journal of Translational Medicine

Immunothérapie Essais Cliniques Thérapeutique De Défense AccuTOX Anti-cancer
BRIEF

published on 06/06/2024 at 08:05, 1 year 11 months ago

Defence Therapeutics' AccuTOX Study Published in Journal of Translational Medicine

Clinical Trials Immunotherapy Defence Therapeutics AccuTOX Anti-cancer
PRESS RELEASE

published on 06/06/2024 at 08:00, 1 year 11 months ago

DEFENCE’S ACCUTOX PUBLISHED IN THE PRESTIGIOUS JOURNAL OF TRANSLATIONAL MEDICINE ITS PEER STUDY WITH PRECLINICAL DATA ON ACCUTOX AS AN ANTI-CANCER MOLECULE
Defence Therapeutics Inc.'s AccuTOX published in the prestigious Journal of Translational Medicine along with preclinical data on AccuTOX as an anti-cancer molecule. Study highlights AccuTOX's superior therapeutic properties and versatility for different cancer treatments

Preclinical Data Defence Therapeutics Inc. AccuTOX Journal Of Translational Medicine Anti-cancer Molecule
BRIEF

published on 05/14/2024 at 08:05, 1 year 11 months ago

Defence Therapeutics étend son portefeuille de brevets à l'échelle mondiale

Thérapeutique De Défense Délivrance De Brevet Innovation Dans Les Soins De Santé Vaccin Immuno-oncologique Système De Délivrance De Médicaments
BRIEF

published on 05/14/2024 at 08:05, 1 year 11 months ago

Defence Therapeutics Expands Patent Portfolio Globally

Defence Therapeutics Patent Issuance Drug Delivery System Innovation In Healthcare Immune-Oncology Vaccine
PRESS RELEASE

published on 05/14/2024 at 08:00, 1 year 11 months ago

DEFENCE THERAPEUTICS STRENGTHENS AND EXPANDS GLOBAL PATENT PROTECTION ON KEY TECHNOLOGIES
Defence Therapeutics strengthens and expands global patent protection on key technologies, including vaccine enhancer platform and ADC platform technology. The new patents and allowances showcase the company's commitment to innovation in biopharmaceuticals

Biopharmaceuticals Defence Therapeutics Patent Protection Vaccine Enhancer ADC Platform Technology

Accesswire

Published on 05/14/2026 at 00:00, 36 minutes ago

BEACN Announces Creation of Loan Program
Published on 05/13/2026 at 23:30, 1 hour 6 minutes ago

CCL Industries Announces Results for 2026 First Quarter
Published on 05/13/2026 at 23:15, 1 hour 21 minutes ago

Avino Delivers Record Q1 2026 Financial Results
Published on 05/13/2026 at 23:05, 1 hour 31 minutes ago

Vox Royalty Reports Record Q1 2026 Results, Increases 2026 Guidance and Declares Quarterly Dividend
Published on 05/13/2026 at 22:30, 2 hours 6 minutes ago

Amdocs Entitlement Server Sets New Industry Performance Benchmark on Microsoft Azure

View all ACCESSWIRE

EQS Group

Published on 05/13/2026 at 22:20, 2 hours 15 minutes ago

Rumble Announces Initial Results of Exchange Offer for Northern Data
Published on 05/13/2026 at 20:21, 4 hours 15 minutes ago

Northern Data provides operational update
Published on 05/13/2026 at 20:18, 4 hours 17 minutes ago

EQS-Adhoc: Northern Data Group Q1 2026 – Above the Preliminary Ranges Communicated on 8 April 2026
Published on 05/13/2026 at 19:28, 5 hours 7 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/13/2026 at 19:14, 5 hours 21 minutes ago

EQS-Adhoc: Oldenburgische Landesbank AG: Oldenburgische Landesbank AG intends to call its Additional Tier 1 bond

Les Echos

Published on 05/13/2026 at 18:02, 6 hours 34 minutes ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 6 hours 36 minutes ago

DDV monthly statement at April 30 2026
Published on 05/13/2026 at 18:00, 6 hours 36 minutes ago

DDV declaration au 30 avril 2026
Published on 05/13/2026 at 18:00, 6 hours 36 minutes ago

ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
Published on 05/13/2026 at 17:45, 6 hours 51 minutes ago

Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.

View all LES ECHOS COMFI WIRE